Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relistor for Opioid-induced Pharyngeal and Esophageal Dysfunction
NCT01012960Phase 4Completed
- Sponsor
- Region Örebro län
- Start
- Nov 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylnaltrexone in oropharyngeal dysphagia, opioid-induced esophageal dysfunction (OIED), sponsored by Region Örebro län. Started Nov 2009; status: completed.
02
Drugs
methylnaltrexone
03
Conditions
oropharyngeal dysphagiaopioid-induced esophageal dysfunction (OIED)
Beyond the preview
Go deeper on NCT01012960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01012960.